Prescription drug · ANDA
Diclofenac Sodium NDC 61314-014
Diclofenac sodium 1 mg/mL · Solution · Ophthalmic · Sandoz Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 61314-014-05 | 61314001405 | 1 BOTTLE in 1 CARTON (61314-014-05) / 5 mL in 1 BOTTLEMarketed from Feb 14, 2018 | |
| 61314-014-25 | 61314001425 | 1 BOTTLE in 1 CARTON (61314-014-25) / 2.5 mL in 1 BOTTLEMarketed from Feb 14, 2018 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Diclofenac Sodium
- Generic name (nonproprietary)
- diclofenac sodium
- Active ingredients
- Diclofenac sodium — 1 mg/mL
- Dosage form
- Solution
- Route
- Ophthalmic
- Labeler
- Sandoz Inc
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 078031
- Marketing start
- Listing expires
- Other FDA classes
- Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)Decreased Prostaglandin Production (Physiologic effect)
- Identifiers
- Product ID 61314-014_202278f8-31f7-4c24-ae96-8065430d6a7dSPL ID 202278f8-31f7-4c24-ae96-8065430d6a7dSPL set ID 52d22a6b-3acd-4694-9df5-8cfa9cc2bb2bRxCUI 854801UNII QTG126297Q
- Pharmacologic class
- Nonsteroidal Anti-inflammatory Drug
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N461314001405followed by a unit qualifier and the quantityPackage 61314-0014-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Diclofenac sodium ophthalmic solution is indicated for the treatment of postoperative inflammation in patients who have undergone cataract extraction and for the temporary relief of pain and photophobia in patients undergoing corneal refractive surgery.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 078031
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Diclofenac Sodium | Diclofenac sodium 1 mg/mL | SolutionOphthalmic | A-S Medication Solutions | 50090-3568 |